Fulltext

LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

Wick, W. ; Brandes, AA ; Gorlia, T. ; Bendszus, M. ; Sahm, F. ; Taal, W. ; Taphoorn, M. ; Domont, J. ; Idbaih, A. ; Campone, M. ; Clement, P.M. ; Stupp, R. ; Fabbro, M. ; Dubois, F. ; Bais, C. ; Musmeci, D. ; Platten, M. ; Weller, M. ; Golfinopoulos, V. ; van den Bent, M.

In: Neuro-Oncology, 2015, vol. 17, p. v1-v1

Zum persönliche Liste hinzufügen
    Titel
    • LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL
    Autor
    • Wick, W.. University Medical Center & German Cancer Research Center, Heidelberg, Germany
    • Brandes, AA. Medical Oncology Department, AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italia
    • Gorlia, T.. EORTC Headquarters, Brussels, Belgium
    • Bendszus, M.. University Medical Center & German Cancer Research Center, Heidelberg, Germany
    • Sahm, F.. University Medical Center & German Cancer Research Center, Heidelberg, Germany
    • Taal, W.. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • Taphoorn, M.. Medical Center Haaglanden, The Hague, The Netherlands The Netherlands
    • Domont, J.. Institut Gustave Roussy, Villejuif, France
    • Idbaih, A.. AP-HP, Hôpital Universitaire La Pitié Salpêrière and Sorbonne Universités, UPMC Univ Paris 06, Paris, France
    • Campone, M.. Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau, Saint-Herblain, France
    • Clement, P.M.. U.Z. Leuven - KU Leuven, Belgium
    • Stupp, R.. Zurich University Medical Center, Zurich, Switzerland
    • Fabbro, M.. Institut régional du Cancer Montpellier, Montpellier, France
    • Dubois, F.. CHRU de Lille, Lille, France
    • Bais, C.. Genentech Inc., South San Francisco, California, USA
    • Musmeci, D.. EORTC Headquarters, Brussels, Belgium
    • Platten, M.. University Medical Center & German Cancer Research Center, Heidelberg, Germany
    • Weller, M.. Zurich University Medical Center, Zurich, Switzerland
    • Golfinopoulos, V.. EORTC Headquarters, Brussels, Belgium
    • van den Bent, M.. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • Neuro-Oncology, 2015, vol. 17, p. v1-v1. Oxford University Press
    Andere elektronische Ausgabe
    Klassifikation
    • Gesundheit
    OAI-PMH-ID
    • oai:doc.rero.ch:301206